Cargando…
Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
Apolipoprotein A-I (apoA-I), 90% of which is present in high-density lipoprotein (HDL), is the main constituent of HDL, has anti-inflammatory and anti-oxidant properties, and has received extensive attention in anti-atherosclerosis. Yet little is known about apoA-I ’s role in peritoneal dialysis. In...
Autores principales: | Lu, Jing, Gao, Jie, Sun, Jing, Wang, Haiping, Sun, Huijuan, Huang, Qian, Zhang, Yao, Zhong, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422021/ https://www.ncbi.nlm.nih.gov/pubmed/37576813 http://dx.doi.org/10.3389/fphar.2023.1106339 |
Ejemplares similares
-
Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022) -
Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
por: Lu, Xiaohui, et al.
Publicado: (2023) -
Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022) -
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
por: Huang, Qian, et al.
Publicado: (2022) -
The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)